{"id":840735,"date":"2025-04-23T10:15:27","date_gmt":"2025-04-23T14:15:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/"},"modified":"2025-04-23T10:15:27","modified_gmt":"2025-04-23T14:15:27","slug":"lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/","title":{"rendered":"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <i>Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">BEIJING<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 23, 2025<\/span><\/span> \/PRNewswire\/ &#8212; On <span class=\"xn-chron\">April 18<\/span>, 2025,\u00a0LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (&#8220;LakeShore Biopharma&#8221; or the &#8220;Company&#8221;) successfully held the 2025 CSO (&#8220;Contract Sales Organization&#8221;)\u00a0Annual Meeting and the launch meeting of YSJA\u2122\u00a0rabies vaccine\u00a0(Vero cell) novel\u00a0packaging solution (liquid drug transfer device) in <span class=\"xn-location\">Changsha<\/span>, <span class=\"xn-location\">Hunan Province<\/span>. Approved for lot release by regulatory authorities on <span class=\"xn-chron\">April 15, 2025<\/span>, the new formulation will begin nationwide distribution in <span class=\"xn-location\">China<\/span> within weeks, addressing critical safety challenges in vaccine administration.<\/p>\n<p>To address pain points such as compounding contamination, occupational exposure of medical staff and needle tip pain, the novel packaging YSJA\u2122\u00a0vaccine has been upgraded accordingly. In addition, the novel packaging\u00a0product is equipped with specially designed clasp, puncture device and suction head, which can realize automatic clamping, needle-free reconstitution and new needle injection, improve the convenience and safety of vaccination, reduce the risk of particle pollution and inflammation, and protect medical staff from needlestick injuries. The new packaging product of YSJA\u2122 rabies vaccine has filled the gap in the Chinese market, and its innovative design was highly recognized by the CSOs participating in the conference.<\/p>\n<p>&#8220;The YSJA\u2122 packaging innovation represents humanized design in vaccine delivery,&#8221; stated Mr. Wang\u00a0Xu, CEO of LakeShore Biopharma. &#8220;By leveraging closed sterile connection technology, this novel design will gradually address the industry pain points of &#8220;occupational exposure and pollution risk&#8221; in the traditional liquid preparation process. This launch marks the first commercial application of such advanced liquid transfer device in <span class=\"xn-location\">China&#8217;s<\/span> rabies vaccine market, filling a significant unmet need.&#8221; With rabies remaining a critical public health threat in endemic regions, the company will continue to be committed to empowering medical safety with science and technology in the future.<\/p>\n<p>For media inquiries, please contact:<br \/>Website: <a href=\"https:\/\/investors.lakeshorebio.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/investors.lakeshorebio.com\/<\/a><br \/>Email: <a href=\"mailto:ir@lakeshorebio.com\" target=\"_blank\" rel=\"nofollow\">ir@lakeshorebio.com<\/a>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell-302435932.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell-302435932.html<\/a><\/p>\n<p>SOURCE  LakeShore Biopharma Co., Ltd.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CN70978&amp;Transmission_Id=202504230935PR_NEWS_USPR_____CN70978&amp;DateId=20250423\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING , April 23, 2025 \/PRNewswire\/ &#8212; On April 18, 2025,\u00a0LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (&#8220;LakeShore Biopharma&#8221; or the &#8220;Company&#8221;) successfully held the 2025 CSO (&#8220;Contract Sales Organization&#8221;)\u00a0Annual Meeting and the launch meeting of YSJA\u2122\u00a0rabies vaccine\u00a0(Vero cell) novel\u00a0packaging solution (liquid drug transfer device) in Changsha, Hunan Province. Approved for lot release by regulatory authorities on April 15, 2025, the new formulation will begin nationwide distribution in China within weeks, addressing critical safety challenges in vaccine administration. To address pain points such as compounding contamination, occupational exposure of medical staff and needle tip pain, the novel packaging YSJA\u2122\u00a0vaccine has been upgraded accordingly. In addition, the novel packaging\u00a0product is equipped with specially &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-840735","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING , April 23, 2025 \/PRNewswire\/ &#8212; On April 18, 2025,\u00a0LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (&#8220;LakeShore Biopharma&#8221; or the &#8220;Company&#8221;) successfully held the 2025 CSO (&#8220;Contract Sales Organization&#8221;)\u00a0Annual Meeting and the launch meeting of YSJA\u2122\u00a0rabies vaccine\u00a0(Vero cell) novel\u00a0packaging solution (liquid drug transfer device) in Changsha, Hunan Province. Approved for lot release by regulatory authorities on April 15, 2025, the new formulation will begin nationwide distribution in China within weeks, addressing critical safety challenges in vaccine administration. To address pain points such as compounding contamination, occupational exposure of medical staff and needle tip pain, the novel packaging YSJA\u2122\u00a0vaccine has been upgraded accordingly. In addition, the novel packaging\u00a0product is equipped with specially &hellip; Continue reading &quot;LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-23T14:15:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)\",\"datePublished\":\"2025-04-23T14:15:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/\"},\"wordCount\":333,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN70978&amp;sd=2025-04-23\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/\",\"name\":\"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN70978&amp;sd=2025-04-23\",\"datePublished\":\"2025-04-23T14:15:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN70978&amp;sd=2025-04-23\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN70978&amp;sd=2025-04-23\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/","og_locale":"en_US","og_type":"article","og_title":"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell) - Market Newsdesk","og_description":"PR Newswire Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING , April 23, 2025 \/PRNewswire\/ &#8212; On April 18, 2025,\u00a0LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) (&#8220;LakeShore Biopharma&#8221; or the &#8220;Company&#8221;) successfully held the 2025 CSO (&#8220;Contract Sales Organization&#8221;)\u00a0Annual Meeting and the launch meeting of YSJA\u2122\u00a0rabies vaccine\u00a0(Vero cell) novel\u00a0packaging solution (liquid drug transfer device) in Changsha, Hunan Province. Approved for lot release by regulatory authorities on April 15, 2025, the new formulation will begin nationwide distribution in China within weeks, addressing critical safety challenges in vaccine administration. To address pain points such as compounding contamination, occupational exposure of medical staff and needle tip pain, the novel packaging YSJA\u2122\u00a0vaccine has been upgraded accordingly. In addition, the novel packaging\u00a0product is equipped with specially &hellip; Continue reading \"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-23T14:15:27+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)","datePublished":"2025-04-23T14:15:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/"},"wordCount":333,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/","name":"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23","datePublished":"2025-04-23T14:15:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN70978&amp;sd=2025-04-23"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-solution-for-ysja-rabies-vaccine-vero-cell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA\u2122 Rabies Vaccine (Vero Cell)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=840735"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840735\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=840735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=840735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=840735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}